Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 27

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Relationships between cytokines and cognitive function from pre- to post-chemotherapy in patients with breast cancer

Janelsins, Michelle C., Lei, Lianlian, Netherby-Winslow, Colleen, Kleckner, Amber S., Kerns, Sarah, Gilmore, Nikesha, Belcher, Elizabeth, Thompson, Bryan D., Werner, Zachary A., Hopkins, Judith O., Long, Joan, Cole, Sharon, Culakova, Eva·2022·Journal of Neuroimmunology
DOI 10.1016/j.jneuroim.2021.577769
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jneuroim.2021.577769

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 45

  1. Ahles, 2008, Cognitive function in breast cancer patients prior to adjuvant treatment, Breast Cancer Res. Treat., 110, 143, 10.1007/s10549-007-9686-5 · DOI
  2. Andreotti, 2015, Cancer, coping, and cognition: a model for the role of stress reactivity in cancer-related cognitive decline, Psychooncology, 24, 617, 10.1002/pon.3683 · DOI
  3. Bettcher, 2019, Increases in a pro-inflammatory chemokine, MCP-1, are related to decreases in memory over time, Front. Aging Neurosci., 11, 25, 10.3389/fnagi.2019.00025 · DOI
  4. Castel, 2017, Biomarkers associated with cognitive impairment in treated cancer patients: potential predisposition and risk factors, Front. Pharmacol., 8, 138, 10.3389/fphar.2017.00138 · DOI
  5. Cerulla, 2017, Role of taxanes in chemotherapy-related cognitive impairment: a prospective longitudinal study, Breast Cancer Res. Treat., 164, 179, 10.1007/s10549-017-4240-6 · DOI
  6. Cheung, 2015, Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study, Ann. Oncol., 26, 1446, 10.1093/annonc/mdv206 · DOI
  7. Drachman, 1972, Memory impairment in the aged: storage versus retrieval deficit, J. Exp. Psychol., 93, 302, 10.1037/h0032489 · DOI
  8. Fray, 1996, CANTAB battery: proposed utility in neurotoxicology, Neurotoxicol. Teratol., 18, 499, 10.1016/0892-0362(96)00027-X · DOI
  9. Ganz, 2011, Does circulating tumor necrosis factor (TNF) play a role in post-chemotherapy cerebral dysfunction in breast cancer survivors (BCS)?, J. Clin. Oncol., 29, 9008, 10.1200/jco.2011.29.15_suppl.9008 · DOI
  10. Ganz, 2013, Does tumor necrosis factor-alpha (TNF-alpha) play a role in post-chemotherapy cerebral dysfunction?, Brain Behav. Immun., 30, S99, 10.1016/j.bbi.2012.07.015 · DOI
  11. Gaudino, 1995, Construct validity in the trail making test: what makes part B harder?, J. Clin. Exp. Neuropsychol., 17, 529, 10.1080/01688639508405143 · DOI
  12. Goul, 1970, Effects of age and intelligence on trail making test performance and validity, Percept. Mot. Skills, 30, 319, 10.2466/pms.1970.30.1.319 · DOI
  13. Hayslip, 2015, Plasma TNF-alpha and soluble TNF receptor levels after doxorubicin with or without co-administration of Mesna-A randomized, cross-over clinical study, PLoS One, 10, 10.1371/journal.pone.0124988 · DOI
  14. Henneghan, 2018, Identifying cytokine predictors of cognitive functioning in breast cancer survivors up to 10 years post chemotherapy using machine learning, J. Neuroimmunol., 320, 38, 10.1016/j.jneuroim.2018.04.012 · DOI
  15. Janelsins, 2011, Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research, Support Care Cancer
  16. Janelsins, 2012, Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research, Support Care Cancer, 20, 831
  17. Janelsins, 2014, Prevalence, mechanisms, and management of cancer-related cognitive impairment, Int. Rev. Psychiatry, 26, 102, 10.3109/09540261.2013.864260 · DOI · Paper page
  18. Janelsins, 2018, Longitudinal trajectory and characterization of cancer-related cognitive impairment in a nationwide cohort study, J. Clin. Oncol., 10.1200/JCO.2018.78.6624 · DOI
  19. Jenkins, 2016, A feasibility study exploring the role of pre-operative assessment when examining the mechanism of 'chemo-brain' in breast cancer patients, Springerplus, 5, 390, 10.1186/s40064-016-2030-y · DOI
  20. Kesler, 2011, Prefrontal cortex and executive function impairments in primary breast cancer, Arch. Neurol., 8, 1447, 10.1001/archneurol.2011.245 · DOI
  21. Kesler, 2013, Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors, Brain Behav. Immun., 30, S109, 10.1016/j.bbi.2012.05.017 · DOI
  22. Kesler, 2016, Neurotoxic effects of Anthracycline- vs Nonanthracycline-based chemotherapy on cognition in breast cancer survivors, JAMA Oncol., 2, 185, 10.1001/jamaoncol.2015.4333 · DOI
  23. Korde, 2021, Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline, J. Clin. Oncol., 39, 1485, 10.1200/JCO.20.03399 · DOI
  24. Lee, 2018, Plasma MCP-1 and cognitive decline in patients with Alzheimer’s disease and mild cognitive impairment: a two-year follow-up study, Sci. Rep., 8, 1280, 10.1038/s41598-018-19807-y · DOI
  25. Lezak, 1979, Recovery of memory and learning functions following traumatic brain injury, Cortex, 15, 63, 10.1016/S0010-9452(79)80007-6 · DOI
  26. Lyon, 2016, Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer, J. Neuroimmunol., 301, 74, 10.1016/j.jneuroim.2016.11.002 · DOI
  27. Maggio, 2006, Interleukin-6 in aging and chronic disease: a magnificent pathway, J. Gerontol. A Biol. Sci. Med. Sci., 61, 575, 10.1093/gerona/61.6.575 · DOI
  28. Miller, 2013, Cytokine targets in the brain: impact on neurotransmitters and neurocircuits, Depress. Anxiety, 30, 297, 10.1002/da.22084 · DOI · Paper page
  29. Mills, 2008, Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer, Brain Behav. Immun., 22, 98, 10.1016/j.bbi.2007.07.001 · DOI
  30. Oppegaard, 2021, Cancer-related cognitive impairment is associated with perturbations in inflammatory pathways, Cytokine, 148, 10.1016/j.cyto.2021.155653 · DOI
  31. Patel, 2015, Inflammatory biomarkers, comorbidity, and neurocognition in women with newly diagnosed breast cancer, J. Natl. Cancer Inst., 107, 10.1093/jnci/djv131 · DOI
  32. Pusztai, 2004, Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy, Cytokine, 25, 94, 10.1016/j.cyto.2003.10.004 · DOI
  33. Rasmusson, 1995, Stability of performance on the Hopkins verbal learning test, Arch. Clin. Neuropsychol., 10, 21, 10.1093/arclin/10.1.21 · DOI
  34. Ren, 2017, Dysregulation of cytokine mediated chemotherapy induced cognitive impairment, Pharmacol. Res., 117, 267, 10.1016/j.phrs.2017.01.001 · DOI
  35. Robbins, 1994, Cambridge neuropsychological test automated battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers, Dementia, 5, 266
  36. Rodriguez Martin, 2020, Study of chemotherapy-induced cognitive impairment in women with breast Cancer, Int. J. Environ. Res. Public Health, 17, 10.3390/ijerph17238896 · DOI
  37. Shapiro, 1999, Construct and concurrent validity of the Hopkins verbal learning test-revised, Clin. Neuropsychol., 13, 348, 10.1076/clin.13.3.348.1749 · DOI
  38. Svob Strac, 2016, The serotonergic system and cognitive function, Transl. Neurosci., 7, 35, 10.1515/tnsci-2016-0007 · DOI
  39. Villani, 2008, Serum cytokine in response to chemo-radiotherapy for Hodgkin's disease, Tumori, 94, 803, 10.1177/030089160809400605 · DOI
  40. Von Ah, 2013, Impact of perceived cognitive impairment in breast cancer survivors, Eur. J. Oncol. Nurs., 17, 236, 10.1016/j.ejon.2012.06.002 · DOI
  41. Wang, 2015, Chemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy, Cytokine, 72, 86, 10.1016/j.cyto.2014.12.006 · DOI
  42. Wardill, 2016, Cytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy-associated neurotoxicity and cognitive dysfunction, Int. J. Cancer, 139, 2635, 10.1002/ijc.30252 · DOI
  43. Wefel, 2004, The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial, Cancer, 100, 2292, 10.1002/cncr.20272 · DOI
  44. Wefel, 2015, Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults, CA Cancer J. Clin., 65, 123
  45. Williams, 2018, Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy, J. Neuroimmunol., 314, 17, 10.1016/j.jneuroim.2017.10.005 · DOI

Metadata

Authors
Janelsins, M. C., Lei, L., Netherby-Winslow, C., Kleckner, A. S., Kerns, S., Gilmore, N., Belcher, E., Thompson, B. D., Werner, Z. A., Hopkins, J. O., Long, J., Cole, S., & Culakova, E.
Venue
Journal of Neuroimmunology
Publisher
Elsevier BV
Published
2022-01
Volume
362
Pages
577769
ISSN
0165-5728
DOI
10.1016/j.jneuroim.2021.577769
Cited by
27
References
4
Language
en
Licence
Funders
  • National Institutes of Health
  • National Cancer Institute (K07CA168886, K07CA187546, R01CA231014, T32 CA102618, U10CA037420, UG1CA189961)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Relationships between cytokines and cognitive function from pre- to post-chemotherapy in patients with breast cancer. https://app.cochat.ai/papers/10.1016/j.jneuroim.2021.577769
The paper
Janelsins, M. C., Lei, L., Netherby-Winslow, C., Kleckner, A. S., Kerns, S., Gilmore, N., Belcher, E., Thompson, B. D., Werner, Z. A., Hopkins, J. O., Long, J., Cole, S., & Culakova, E. (2022). Relationships between cytokines and cognitive function from pre- to post-chemotherapy in patients with breast cancer. Journal of Neuroimmunology. https://doi.org/10.1016/j.jneuroim.2021.577769

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.